Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- Section 2 Management Commentaries
- 18 Introduction to Management Commentaries
- 19 Management Commentary
- 20 Management Commentary
- 21 Management Commentary
- 22 Management Commentary
- 23 Management Commentary
- 24 Management Commentary
- 25 Management Commentary
- 26 Management Commentary
- 27 Management Commentary
- 28 Management Commentary
- 29 Management Commentary
- 30 Management Commentary
- 31 Management Commentary
- 32 Management Commentary
- 33 Management commentary
- 34 Management Commentary
- 35 Management Commentary
- 36 Management Commentary
- Section 3 Conclusion
- Index
- References
35 - Management Commentary
from Section 2 - Management Commentaries
Published online by Cambridge University Press: 17 December 2018
Edited by
Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- Section 2 Management Commentaries
- 18 Introduction to Management Commentaries
- 19 Management Commentary
- 20 Management Commentary
- 21 Management Commentary
- 22 Management Commentary
- 23 Management Commentary
- 24 Management Commentary
- 25 Management Commentary
- 26 Management Commentary
- 27 Management Commentary
- 28 Management Commentary
- 29 Management Commentary
- 30 Management Commentary
- 31 Management Commentary
- 32 Management Commentary
- 33 Management commentary
- 34 Management Commentary
- 35 Management Commentary
- 36 Management Commentary
- Section 3 Conclusion
- Index
- References
- Type
- Chapter
- Information
- Bipolar II DisorderModelling, Measuring and Managing, pp. 281 - 284Publisher: Cambridge University PressPrint publication year: 2019
References
Amsterdam, J. D., Luo, L. L. and Shults, J. (2013). Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder. British Journal of Psychiatry, 202, 301–6.Google Scholar
Amsterdam, J. D., Lorenzo-Luaces, L., Soeller, I., et al. (2015). Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: a randomized, double-blind, parallel-group, prospective study. Journal of Affective Disorders, 185, 31–7.Google Scholar
Bond, D. J., Noronha, M. M., Kauer-Sant'Anna, M. et al. (2008). Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis, Journal of Clinical Psychiatry, 69, 1589–601.Google Scholar
Calabrese, J. R., Pikalov, A., Streicher, C. et al. (2017). Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder. European Neuropsychopharmacology, 27, 865–87CrossRefGoogle ScholarPubMed
Geddes, J. R., Calabrese, J. R. and Goodwin, G. M. (2009). Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry, 194, 4–9.CrossRefGoogle ScholarPubMed
Yatham, L. N., Kennedy, S. H., Parikh, S. V. et al. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders, 15, 1–44.Google Scholar
Young, A. H., Calabrese, J. R., Gustafsson, U. et al. (2013). Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. International Journal of Bipolar Disorders, 1, 10.CrossRefGoogle ScholarPubMed
- 1
- Cited by